Nasdaq

Eisai: Metoject Subcutaneous Injection Syringe (Methotrexate) Approved in Japan for Rheumatoid Arthritis

TOKYO, Sept 26, 2022 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today that they have obtained ...
The American Journal of Managed Care

Methotrexate, Leflunomide Treatment Associated With Increased Possibility of Adverse Pregnancy Outcomes in Patients With RA

Pregnant female patients with rheumatoid arthritis (RA) treated with methotrexate and leflunomide within 3 months of conception faced an increased possibility of adverse pregnancy outcomes, ...
Medscape

Tocilizumab, Alone or With Methotrexate, Potent in Active RA

Subcutaneous tocilizumab, either as monotherapy or in combination with methotrexate, demonstrated greater efficacy than methotrexate alone and was well tolerated in patients with active rheumatoid ...
The American Journal of Managed Care

Network Meta-Analysis Validates the Use of Methotrexate in RA Compared With Other Treatments

A network meta-analysis confirmed the efficacy of methotrexate for patients with rheumatoid arthritis (RA) and validated it as the primary reference conventional synthetic disease-modifying ...
Medscape

Second try with methotrexate may work in RA

Vienna, Austria - Patients with rheumatoid arthritis (RA) who had inadequate response to a first course of methotrexate but have not had major toxicity may be good candidates for a second round of ...
Monthly Prescribing Reference

Intravitreal Methotrexate NDA Submitted for Primary Vitreoretinal Lymphoma

Credit: Getty Images. ADX-2191 is a preservative-free, intravitreal formulation of methotrexate designed to be vitreous-compatible. The New Drug Application (NDA) for ADX-2191 (methotrexate injection) ...